mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 66.7% | ‑2.0 / 11.2 | 21 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 3,234,344 | 0 | T | G | 60.0% | 2.9 / 20.2 | 20 | S348A (TCT→GCT) | sstT | serine/threonine transporter SstT |
| * | NZ_CP009273 | 3,659,062 | 0 | C | A | 60.0% | ‑2.9 / 14.5 | 15 | A37S (GCG→TCG) | gadX | acid resistance transcriptional activator GadX |
| * | NZ_CP009273 | 322,525 | 0 | A | C | 58.8% | 13.8 / 15.6 | 17 | V145G (GTG→GGG) | betA | choline dehydrogenase |
| * | NZ_CP009273 | 2,778,686 | 0 | T | G | 58.3% | 5.2 / 11.0 | 12 | intergenic (‑316/+435) | BW25113_RS25705/BW25113_RS13825 | DUF5507 domain‑containing protein/tRNA‑Ile |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 57.1% | ‑1.2 / 16.1 | 21 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 1,698,302 | 0 | A | C | 54.5% | 8.8 / 11.2 | 11 | G88G (GGT→GGG) | ydgJ | oxidoreductase |
| * | NZ_CP009273 | 3,168,592 | 0 | A | C | 54.5% | 7.7 / 11.4 | 11 | V55G (GTG→GGG) | parE | DNA topoisomerase IV subunit B |
| * | NZ_CP009273 | 3,941,200 | 0 | A | C | 54.5% | 2.3 / 10.7 | 11 | L43R (CTG→CGG) | hdfR | HTH‑type transcriptional regulator HdfR |
| * | NZ_CP009273 | 172,755 | 0 | A | G | 53.3% | 4.8 / 11.8 | 15 | T388A (ACG→GCG) | clcA | H(+)/Cl(‑) exchange transporter ClcA |
| * | NZ_CP009273 | 3,659,058 | 0 | T | C | 53.3% | 7.5 / 13.0 | 15 | D38G (GAT→GGT) | gadX | acid resistance transcriptional activator GadX |